Primary effects of intravitreal bevacizumab in patients with diabetic macular edema.

Intravitreal injection of Bevacizumab in diabetic macular edema. Pak J Med Sci (2015) 0.75

Global and societal implications of the diabetes epidemic. Nature (2001) 25.18

Vascular endothelial growth factor: basic science and clinical progress. Endocr Rev (2004) 11.69

Intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration. Ophthalmology (2006) 9.01

The Wisconsin epidemiologic study of diabetic retinopathy. IV. Diabetic macular edema. Ophthalmology (1984) 5.91

Intravitreal bevacizumab (Avastin) in the treatment of proliferative diabetic retinopathy. Ophthalmology (2006) 4.48

Treatment techniques and clinical guidelines for photocoagulation of diabetic macular edema. Early Treatment Diabetic Retinopathy Study Report Number 2. Early Treatment Diabetic Retinopathy Study Research Group. Ophthalmology (1987) 3.63

Intravitreal bevacizumab (Avastin) therapy for persistent diffuse diabetic macular edema. Retina (2006) 3.09

Intravitreal triamcinolone for refractory diabetic macular edema: two-year results of a double-masked, placebo-controlled, randomized clinical trial. Ophthalmology (2006) 2.72

Sustained delivery fluocinolone acetonide vitreous inserts provide benefit for at least 3 years in patients with diabetic macular edema. Ophthalmology (2012) 2.32

Vitrectomy for diffuse diabetic macular edema associated with a taut premacular posterior hyaloid. Am J Ophthalmol (2000) 1.76

Primary intravitreal bevacizumab for diffuse diabetic macular edema: the Pan-American Collaborative Retina Study Group at 24 months. Ophthalmology (2009) 1.38

Complications of intravitreal injection of triamcinolone acetonide. Can J Ophthalmol (2005) 1.33

Reduction of diabetic macular edema by oral administration of the kinase inhibitor PKC412. Invest Ophthalmol Vis Sci (2004) 1.20

Vitreous levels of vascular endothelial growth factor and intercellular adhesion molecule 1 are related to diabetic macular edema. Ophthalmology (2005) 1.20

Intravitreal bevacizumab (Avastin) treatment of diffuse diabetic macular edema in an Indian population. Indian J Ophthalmol (2007) 0.90

Intravitreal bevacizumab (Avastin) for primary treatment of diabetic macular oedema. Eye (Lond) (2008) 0.90

Prevalence of diabetic retinopathy in Pakistani subjects. A pilot study. J Pak Med Assoc (1991) 0.88

Short term results of intra-vitreal bevacizumab for the treatment of macular edema secondary to retinal vein occlusion. Nepal J Ophthalmol (2013) 0.79